décembre
Langsted A, Nordestgaard BG, et al. Thromb Haemost 2019 ; 119 : 39-47.
Marconi C, Di Buduo CA, LeVine K, Barozzi S, Faleschini M, Bozzi V, et al. Blood 2019 ; 133 : 1346-57.
Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Tagawa ST, et al. Blood 2019 ; 133 : 781-9.
Peyvandi F, Mamaev A, Wang JD, Stasyshyn O, Timofeeva M, Curry N, et al. J Thromb Haemost 2019 ; 17 : 52-62.
Fanny LASSALLE Tribune’K Hémostase 2019 ; 2 (10) : A11 Roetker NS, Lutsey PL, Zakai NA, Alonso A, Adam TJ, MacLehose RF. All-cause mortality risk with direct oral anticoagulants and warfarin in the primary treatment of venous thromboembolism. Thromb Haemost 2018 ; 118 : 1637‑45.
Annabelle DUPONT Tribune’K Hémostase 2019 ; 2 (10) : A10 Lavin M, Aguila S, Dalton N, Nolan M, Byrne M, Ryan K. Significant gynecological bleeding in women with low von Willebrand factor levels. J Thromb Haemost 2018 ; 16 : 1580‑91.
American Society of Hematology San Diego, Etats-Unis
Carrier M, Abou-Nassar K, Mallick R, Tagalakis V, Shivakumar S, Schattner A, et al. N Engl J Med 2019 ; 380 : 711-9.
novembre
Skeith L, et al. Blood 2018 ; 132 : 2219-29.
Annabelle DUPONT Tribune’K Hémostase 2019 ; 2 (9) : A9 Pengo V, Denas G, Zoppellaro G, Padayattil Jose S, Hoxha A, Ruffatti A. Rivaroxaban versus warfarin in high-risk patients with antiphospholipid syndrom. Blood 2018 ; 132 : 1365-71.
octobre
Kibler M, Marchandot B, Messas N, Labreuche J, Vincent F, Grunebaum L, et al. J Am Coll Cardiol 2018 ; 72 : 2139-48.
Schneppenheim R, Hellermann N, Brehm MA, Klemm U, Obser T, Huck V, et al. Blood 2019 ; 133 : 356-65.
Candy V, Whitworth H, Grabell J, Thibeault L, Harpell L, Bowman M, et al. Blood Adv 2018 ; 2 : 2629-36.
Annabelle DUPONT Tribune’K Hémostase 2019 ; 2 (8) : A8 Hartmann R, Feenstra T, Valentino L, Dockal M, Scheiflinger F. In vitro studies show synergistic effects of a procoagulant bispecific antibody and bypassing agents. J Thromb Haemost 2018 ; 16 : 1580‑91.
septembre
Eichler H, Angchaisuksiri P, Kavakli K, Knoebl P, Windyga J, Jiménez-Yuste V, et al. J Thromb Haemost 2018 ; 16: 2184-95.
Laurent FRENZEL Tribune’K Hémostase 2019 ; 2 (7) : A7 Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR. Platelet Counts during Pregnancy. N Engl J Med 2018 ; 379 : 32-43.
Goel R1, Patel EU, Cushing MM, Frank SM, Ness PM, Takemoto CM, et al. JAMA Surg 2018 ; 153 : 826-33.
août
Mahlangu J, Oldenburg J, Paz-Priel I, Negrier C, Niggli M, Mancuso ME, et al. N Engl J Med 2018 ; 379 : 811-22.
Yada K, Nogami K, Shinozawa K, Kitazawa T, Hattori K, Amano K, et al. Br J Haematol 2018 ; 183 : 257-66.
juillet
Chenaf C, Kaboré JL, Delorme J, Pereira B, Mulliez A, Zenut M, et al. Eur J Pain 2019 ; 23 : 124-34.
Lavin M, Aguila S, Dalton N, Nolan M, Byrne M, Ryan K, et al. Blood Adv 2018 ; 2 : 1784-91.
Wyseure T, Cooke EJ, Declerck PJ, Behrendt N, Meijers JCM, von Drygalski A, et al. Blood 2018 ; 132 : 1593-1603.
Laurent FRENZEL Tribune’K Hémostase 2019 ; 2 (6) : A6 Maas C, Renné T. Coagulation factor XII in thrombosis and inflammation. Blood 2018 ; 131 : 1903-9.
Pengo V, Denas G, Zoppellaro G, Jose SP, Hoxha A, Ruffatti A, et al. Blood 2018 ; 132 : 1365-71.
Lai JD, Swystun LL, Cartier D, Nesbitt K, Zhang C, Hough C, et al. Haematologica ; 103 : 1925-36.
Vázquez-Santiago M, Vilalta N, Cuevas B, Murillo J, Llobet D, Macho R, et al. Thromb Res 2018 ; 169 : 57-63.
Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR, et al. N Engl J Med 2018 ; 379 : 32-43.
juin
Florian CHEVILLON Tribune’K Hémostase 2019 ; 2 (5) : A5 Kearon C, Parpia S, Spencer FA, Baglin T, Stevens SM, Bauer KA. Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism. Blood 2018 ; 131 : 2151-60.
Hartmann R, Feenstra T, Valentino L, Dockal M, Scheiflinger F, et al. J Thromb Haemost 2018 [Epub ahead of print]
mai
Xu M, Li J, Neves MAD, Zhu G, Carrim N, Yu R, et al. Blood 2018 ; 132 : 622-34.
Haxaire C, Hakobyan N, Pannellini T, Carballo C, McIlwain D, Mak TW, et al. Blood 2018 ; 132 : 1064-74.
Sprigg N, Flaherty K, Appleton JP, Al-Shahi Salman R, Bereczki D, Beridze M, et al. Lancet 2018 ; 391 : 2107-15.
Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C, et al. J Clin Oncol 2018 ; 36 : 2017-23.
avril
Laurent FRENZEL Tribune’K Hémostase 2019 ; 2 (4) : A4 Miesbach W, Meijer K, Coppens M, Kampmann P, Klamroth R, Schutgens R. Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B. Blood 2018 ; 131 : 1022-31.
mars
Florian CHEVILLON Tribune’K Hémostase 2019 ; 2 (3) : A3 Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D. Edoxaban for the treatment of cancer-associated venous thromboembolism. N Engl J Med 2018 ; 378 : 615-24.
février
Kearon C, Parpia S, Spencer FA, Baglin T, Stevens SM, Bauer KA, et al. Blood 2018 ; 131 : 2151-60.
Laurent FRENZEL Tribune’K Hémostase 2019 ; 2 (2) : A2 George LA, Sullivan SK, Giermasz A, Rasko JEJ, Samelson-Jones BJ, Ducore J. Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant. N Engl J Med 2017 ; 377 : 2215-27.
Maas C, Renné T, et al. Blood 2018 ; 131 : 1903-9.
Quach ME, Chen W, Li R, et al. Blood 2018 ; 131 : 1512-21.
European Association of Hemophilia and Allied Disorders Madrid, Espagne
janvier
Florian CHEVILLON Tribune’K Hémostase 2019 ; 2 (1) : A1 Rangarajan S, Walsh L, Lester W, Perry D, Madan B, Laffan M. AAV5-Factor VIII Gene Tranfer in Severe Hemophilia A. N Engl J Med. 2017 ; 377 (26) : 2519-30.
Loomans JI, Kruip MJHA, Carcao M, Jackson S, van Velzen AS, Peters M, et al. Haematologica 2018 ; 103 : 550-7.
